Actinium Pharmaceuticals Inc (ATNM)

0.99
AMEX : Health Care
Prev Close 0.97
Day Low/High 0.95 / 1.00
52 Wk Low/High 0.86 / 2.46
Avg Volume 306.30K
Exchange AMEX
Shares Outstanding 55.75M
Market Cap 54.07M
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Actinium Pharmaceuticals To Present At 9th Annual Biotech Showcase™ 2017 Conference 

Actinium Pharmaceuticals To Present At 9th Annual Biotech Showcase™ 2017 Conference 

Actinium to present at 2 PM PST on Tuesday, January 10th

Actinium Pharmaceuticals To Present At 9th Annual Biotech Showcase™ 2017 Conference

Actinium Pharmaceuticals To Present At 9th Annual Biotech Showcase™ 2017 Conference

Actinium to present at 2 PM PST on Tuesday, January 10th

Actinium Further Strengthens Clinical Development Team With Senior Hire To Support Later-Stage Clinical Trials

Actinium Further Strengthens Clinical Development Team With Senior Hire To Support Later-Stage Clinical Trials

Director of Clinical Operations brings nearly two decades of clinical development and pharmaceutical industry experience to Actinium

Actinium Pharmaceuticals To Present At LD Micro Main Event Investor Conference

Actinium Pharmaceuticals To Present At LD Micro Main Event Investor Conference

Presentation scheduled for Tuesday, December 6, 2016 at 11:30 AM PST and management will be available to meet with investors

Actinium Announces Acceptance Of Actimab-A Data For Poster Presentation At American Society Of Hematology Annual Meeting

Actinium Announces Acceptance Of Actimab-A Data For Poster Presentation At American Society Of Hematology Annual Meeting

Data from Phase 1/2 trial to be presented at 58th Annual Meeting

Actinium Announces Closing Of Public Offering Of Common Stock

Actinium Announces Closing Of Public Offering Of Common Stock

Actinium raised total gross proceeds of $10 million

Actinium Pharmaceuticals To Sponsor And Participate In Be The Match® Walk+Run To Raise Awareness For Bone Marrow Transplant

Actinium Pharmaceuticals To Sponsor And Participate In Be The Match® Walk+Run To Raise Awareness For Bone Marrow Transplant

Awareness and Fundraising Event to be Held on Saturday, October 1, 2016

Actinium Pharmaceuticals Selects Vector Oncology As Its Clinical Research Organization For Actimab-A Phase 2 Trial

Actinium Pharmaceuticals Selects Vector Oncology As Its Clinical Research Organization For Actimab-A Phase 2 Trial

CRO Selection Represents Key Milestone in Phase 2 Trial Initiation Process

These 5 Stocks Are Breaking Out

These 5 Stocks Are Breaking Out

Here's how to trade five stocks that are ready to break out and trade higher from current levels.

First Week of March 18th Options Trading For Actinium Pharmaceuticals (ATNM)

First Week of March 18th Options Trading For Actinium Pharmaceuticals (ATNM)

Investors in Actinium Pharmaceuticals, Inc. saw new options begin trading this week, for the March 18th expiration.